2023
Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial
Shah T, McCarthy M, Nasir I, Archer H, Ragheb E, Kluger J, Kashyap N, Paredes C, Patel P, Lu J, Kandel P, Song C, Khan M, Huang H, Haq F, Ahmad R, Howes C, Cambi B, Lancaster G, Cleman M, Dela Cruz C, Parise H, Lansky A. Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial. BMJ Open 2023, 13: e067910. PMID: 36828654, PMCID: PMC9971831, DOI: 10.1136/bmjopen-2022-067910.Peer-Reviewed Original ResearchConceptsStandard of careHigh-intensity rosuvastatinElectronic medical recordsCOVID-19 diseaseMedical recordsPrimary endpointThromboembolic eventsYale New Haven Health SystemSevere COVID-19 diseaseCOVID-19Prespecified primary endpointVenous thromboembolic eventsRisk of progressionCombination of colchicineSafety monitoring boardCare armHispanics/LatinosTherapeutic anticoagulationIndex hospitalisationIll patientsMedian ageFuture trialsEffect of colchicineClinical trialsMonitoring board
2016
Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006–2011)
Arora S, Panaich SS, Patel N, Patel NJ, Lahewala S, Thakkar B, Savani C, Jhamnani S, Singh V, Patel N, Patel S, Sonani R, Patel A, Tripathi B, Deshmukh A, Chothani A, Patel J, Bhatt P, Mohamad T, Remetz MS, Curtis JP, Attaran RR, Mena CI, Schreiber T, Grines C, Cleman M, Forrest JK, Badheka AO. Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006–2011). Catheterization And Cardiovascular Interventions 2016, 88: 605-616. PMID: 26914274, DOI: 10.1002/ccd.26452.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAmputation, SurgicalCross-Sectional StudiesDatabases, FactualDrug CostsEndovascular ProceduresFemaleHospital CostsHospital MortalityHumansLimb SalvageLogistic ModelsLower ExtremityMaleMiddle AgedMultivariate AnalysisOdds RatioPeripheral Arterial DiseasePlatelet Aggregation InhibitorsPlatelet Glycoprotein GPIIb-IIIa ComplexPropensity ScoreRisk FactorsTime FactorsTreatment OutcomeUnited StatesYoung AdultConceptsGlycoprotein IIb/IIIa inhibitorsPeripheral endovascular interventionsHospital mortalityHospitalization costsEndovascular interventionGPI useAmputation rateUtilization Project Nationwide Inpatient Sample databaseTwo-level hierarchical multivariateIIb/IIIa inhibitorsNationwide Inpatient Sample databaseLower amputation ratesPaucity of dataHospital outcomesPostprocedural complicationsSecondary outcomesPropensity matchingStudy cohortHealthcare costsICD-9Multivariate analysisStudy outcomesSample databaseMortalityHierarchical multivariate
2001
Fractional Flow Reserve Compared With Intravascular Ultrasound Guidance for Optimizing Stent Deployment
Fearon W, Luna J, Samady H, Powers E, Feldman T, Dib N, Tuzcu E, Cleman M, Chou T, Cohen D, Ragosta M, Takagi A, Jeremias A, Fitzgerald P, Yeung A, Kern M, Yock P. Fractional Flow Reserve Compared With Intravascular Ultrasound Guidance for Optimizing Stent Deployment. Circulation 2001, 104: 1917-1922. PMID: 11602494, DOI: 10.1161/hc4101.097539.Peer-Reviewed Original ResearchAdenosineAngioplasty, Balloon, CoronaryBlood Flow VelocityBlood Vessel Prosthesis ImplantationCoronary AngiographyCoronary Artery DiseaseCoronary CirculationCoronary VesselsFemaleHumansLikelihood FunctionsMaleMiddle AgedPredictive Value of TestsProspective StudiesROC CurveSensitivity and SpecificityStentsTreatment OutcomeUltrasonography, InterventionalSerum complement activation in congestive heart failure
Clark D, Cleman M, Pfau S, Rollins S, Ramahi T, Mayer C, Caulin-Glaser T, Daher E, Kosiborod M, Bell L, Setaro J. Serum complement activation in congestive heart failure. American Heart Journal 2001, 141: 684-690. PMID: 11275938, DOI: 10.1067/mhj.2001.113758.Peer-Reviewed Original ResearchConceptsCongestive heart failureSymptomatic heart failureC5b-9 levelsHeart failureClinical outcomesC5b-9Control patientsNew York Heart Association class IV symptomsComplement activationAge-matched control patientsClass IV symptomsCombined clinical outcomeAdverse clinical outcomesVentricular ejection fractionTerminal complement complex C5b-9Terminal complement activationComplement complex C5b-9Serum complement activationTerminal complement complexAdverse eventsCardiopulmonary bypassEjection fractionSerum levelsMyocardial injuryMyocardial infarction
2000
Final Results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) Study
Fitzgerald P, Oshima A, Hayase M, Metz J, Bailey S, Baim D, Cleman M, Deutsch E, Diver D, Leon M, Moses J, Oesterle S, Overlie P, Pepine C, Safian R, Shani J, Simonton C, Smalling R, Teirstein P, Zidar J, Yeung A, Kuntz R, Yock P, Investigators F. Final Results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) Study. Circulation 2000, 102: 523-530. PMID: 10920064, DOI: 10.1161/01.cir.102.5.523.Peer-Reviewed Original ResearchConceptsIntravascular ultrasoundQuantitative coronary ultrasoundUltrasound guidanceClinical outcomesStent implantationAngiographic guidanceCoronary ultrasoundStent deploymentLarger minimal lumen diameterStent expansionIVUS-guided groupMinimal lumen diameterQuantitative coronary angiographyMinimal stent areaRoutine ultrasound guidanceVessel revascularizationSurgical therapyCoronary angiographyClinical eventsIndex vesselStent areaRegimen studiesLumen diameterPatientsAngiography
1998
Modulation of Circulating Cellular Adhesion Molecules in Postmenopausal Women With Coronary Artery Disease
Caulin-Glaser T, Farrell W, Pfau S, Zaret B, Bunger K, Setaro J, Brennan J, Bender J, Cleman M, Cabin H, Remetz M. Modulation of Circulating Cellular Adhesion Molecules in Postmenopausal Women With Coronary Artery Disease. Journal Of The American College Of Cardiology 1998, 31: 1555-1560. PMID: 9626834, DOI: 10.1016/s0735-1097(98)00145-4.Peer-Reviewed Original ResearchConceptsE2 replacement therapyCoronary artery diseaseVascular cell adhesion molecule-1Cellular adhesion moleculesPostmenopausal womenAdhesion molecule-1Premenopausal womenArtery diseaseCardioprotective effectsInflammatory responseAdhesion moleculesMolecule-1Incidence of CADControl groupInflammatory cytokine-induced expressionIntercellular adhesion molecule-1Expression of CAMsCell adhesion molecule-1Consecutive eligible subjectsAssociation of estrogenEndothelial cell activationCytokine-induced expressionFemale control groupSignificant increaseEnzyme-linked immunoabsorbant assayEfficacy of Coronary Stenting Versus Balloon Angioplasty in Small Coronary Arteries fn1fn1This study was supported in part by a grant from Johnson & Johnson Interventional Systems, Inc., Warren, New Jersey.
Savage M, Fischman D, Rake R, Leon M, Schatz R, Penn I, Nobuyoshi M, Moses J, Hirshfeld J, Heuser R, Baim D, Cleman M, Brinker J, Gebhardt S, Goldberg S, Investigators F. Efficacy of Coronary Stenting Versus Balloon Angioplasty in Small Coronary Arteries fn1fn1This study was supported in part by a grant from Johnson & Johnson Interventional Systems, Inc., Warren, New Jersey. Journal Of The American College Of Cardiology 1998, 31: 307-311. PMID: 9462572, DOI: 10.1016/s0735-1097(97)00511-1.Peer-Reviewed Original ResearchMeSH KeywordsAngioplasty, Balloon, CoronaryChi-Square DistributionCohort StudiesCoronary AngiographyCoronary DiseaseCoronary VesselsDisease-Free SurvivalElective Surgical ProceduresEquipment DesignFemaleFollow-Up StudiesHumansLinear ModelsMaleMiddle AgedRecurrenceStentsSurvival RateTreatment OutcomeUnited StatesUnited States Food and Drug AdministrationConceptsElective stent placementBalloon angioplastyCoronary arteryStent placementElective stent implantationJohnson Interventional SystemsPostprocedural lumen diameterPrimary end pointEvent-free survivalClinical event ratesSmall coronary arteriesQuantitative coronary angiographyPalmaz-Schatz stentsAngioplasty groupAngiographic characteristicsCoronary angiographyClinical outcomesNew lesionsProcedural successDiameter stenosisStent groupStent implantationAbrupt closurePatientsAngioplasty
1997
Acute and Long-Term Outcome After Palmaz-Schatz Stenting: Analysis From the New Approaches To Coronary Intervention (NACI) Registry
Carrozza J, Schatz R, George C, Leon M, King S, Hirshfeld J, Curry R, Ivanhoe R, Buchbinder M, Cleman M, Goldberg S, Ricci D, Popma J, Safian R, Baim D, Investigators F. Acute and Long-Term Outcome After Palmaz-Schatz Stenting: Analysis From the New Approaches To Coronary Intervention (NACI) Registry. The American Journal Of Cardiology 1997, 80: 78k-88k. PMID: 9409695, DOI: 10.1016/s0002-9149(97)00767-4.Peer-Reviewed Original ResearchConceptsPalmaz-Schatz stentsStent Restenosis StudyTarget lesion revascularizationCoronary Intervention RegistryRecent myocardial infarctionMinimum lumen diameterMyocardial infarctionLesion revascularizationIntervention RegistryProcedural successCoronary arteryHigh riskHigh incidenceLumen diameterSignificant left main stenosisLeft main coronary arteryQ-wave myocardial infarctionPalmaz-Schatz stentingDe novo lesionsLeft main stenosisSaphenous vein graftsCohort of patientsCongestive heart failureMain coronary arteryNative coronary arteriesHigh-Speed Rotational Atherectomy of Human Coronary Stenoses: Acute and One-Year Outcomes From the New Approaches to Coronary Intervention (NACI) Registry
Brown D, George C, Steenkiste A, Cowley M, Leon M, Cleman M, Moses J, King S, Carrozza J, Holmes D, Burkhard-Meier C, Popma J, Brinker J, Buchbinder M, Investigators F. High-Speed Rotational Atherectomy of Human Coronary Stenoses: Acute and One-Year Outcomes From the New Approaches to Coronary Intervention (NACI) Registry. The American Journal Of Cardiology 1997, 80: 60k-67k. PMID: 9409693, DOI: 10.1016/s0002-9149(97)00765-0.Peer-Reviewed Original ResearchConceptsPercutaneous transluminal coronary angioplastyQ-wave MIRotational atherectomyLesion revascularizationCoronary dissectionCoronary stenosisHigh-speed rotational atherectomyNon-Q-wave MIEmergency CABG surgerySpeed rotational atherectomyAngiographic success rateTarget lesion revascularizationOne-year outcomesProcedural success rateTransluminal coronary angioplastyCoronary Intervention RegistrySide branch occlusionSuccess rateNew percutaneous procedureProgression of diseaseHuman coronary stenosisAngiographic complicationsPreprocedural characteristicsCABG surgeryExtensive diseaseStent Placement Compared with Balloon Angioplasty for Obstructed Coronary Bypass Grafts
Savage M, Douglas J, Fischman D, Pepine C, King S, Werner J, Bailey S, Overlie P, Fenton S, Brinker J, Leon M, Goldberg S, Heuser R, Smalling R, Safian R, Cleman M, Buchbinder M, Snead D, Rake R, Gebhardt S. Stent Placement Compared with Balloon Angioplasty for Obstructed Coronary Bypass Grafts. New England Journal Of Medicine 1997, 337: 740-747. PMID: 9287229, DOI: 10.1056/nejm199709113371103.Peer-Reviewed Original ResearchConceptsSaphenous vein graftsBalloon angioplastyStent groupLuminal diameterBypass surgeryBypass graftStent placementAortocoronary venous bypass graftsCoronary artery bypass surgeryBypass graft lesionsMajor cardiac complicationsStandard balloon angioplastyPrimary end pointMajor cardiac eventsCoronary bypass graftsTreatment of stenosisPalmaz-Schatz stentsLargest mean increaseAngioplasty groupAngiographic restenosisCardiac complicationsHemorrhagic complicationsAngiographic outcomesCardiac eventsCoronary angiographyHealth after coronary stenting or balloon angioplasty: Results from the Stent Restenosis Study
Krumholz H, Cohen D, Williams C, Baim D, Brinker J, Cabin H, Heuser R, Hirshfeld J, Leon M, Moses J, Savage M, Cleman M. Health after coronary stenting or balloon angioplasty: Results from the Stent Restenosis Study. American Heart Journal 1997, 134: 337-344. PMID: 9327686, DOI: 10.1016/s0002-8703(97)70065-6.Peer-Reviewed Original ResearchConceptsStent Restenosis StudyCoronary stentingBalloon angioplastyRestenosis StudyDuke Activity Status IndexPalmaz-Schatz coronary stentingCanadian Cardiovascular Society classificationPalmaz-Schatz coronary stent implantationPercutaneous transluminal coronary angioplastyU.S. clinical sitesLong-term HRQoLForm Health SurveyHealth-related qualityMedical Outcomes StudyTransluminal coronary angioplastyCoronary stent implantationConventional balloon angioplastyDisease-specific measuresAngiographic restenosisConventional angioplastyIschemic eventsBodily painConsecutive patientsCoronary angioplastyCardiovascular perspectiveIntracoronary Doppler assessment of moderate coronary artery disease: comparison with 201Tl imaging and coronary angiography. FACTS Study Group.
Heller L, Cates C, Popma J, Deckelbaum L, Joye J, Dahlberg S, Villegas B, Arnold A, Kipperman R, Grinstead W, Balcom S, Ma Y, Cleman M, Steingart R, Leppo J. Intracoronary Doppler assessment of moderate coronary artery disease: comparison with 201Tl imaging and coronary angiography. FACTS Study Group. Circulation 1997, 96: 484-90. PMID: 9244216, DOI: 10.1161/01.cir.96.2.484.Peer-Reviewed Original ResearchConceptsCoronary flow reserveIntracoronary Doppler ultrasoundExercise-induced ischemiaCoronary angiographyFlow reserveDoppler ultrasoundModerate coronary artery diseaseIndependent core laboratoryCoronary artery diseaseStenotic coronary arteriesIntermediate coronary stenosisMaximum heart rateMean stenosisArtery diseaseDoppler assessmentCoronary arteryCoronary stenosisHeart rateStenosisAngiographyCore laboratoryStenosis severityDiagnostic accuracyPhysiological assessmentIschemia
1996
Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators.
Mark D, Talley J, Topol E, Bowman L, Lam L, Anderson K, Jollis J, Cleman M, Lee K, Aversano T, Untereker W, Davidson-Ray L, Califf R. Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators. Circulation 1996, 94: 629-35. PMID: 8772681, DOI: 10.1161/01.cir.94.4.629.Peer-Reviewed Original ResearchMeSH KeywordsAbciximabAgedAngioplastyAntibodies, MonoclonalAnticoagulantsAspirinBlood TransfusionCosts and Cost AnalysisDouble-Blind MethodFemaleHeparinHumansImmunoglobulin Fab FragmentsInfusions, IntravenousInjections, IntravenousMaleMiddle AgedMyocardial IschemiaPlatelet Aggregation InhibitorsPlatelet Glycoprotein GPIIb-IIIa ComplexRecurrenceStentsTreatment OutcomeUnited StatesConceptsHigh-risk coronary angioplastyC7E3 FabIschemic eventsCoronary angioplastyInitial hospitalizationPlatelet glycoprotein IIb/IIIa inhibitionGlycoprotein IIb/IIIa inhibitionIIb/IIIa inhibitionAggressive platelet inhibitionBaseline medical costsIschemic end pointsReduced ischemic eventsAcute ischemic eventsCost of therapyEPIC trialMajor bleedingBleeding episodesIschemic complicationsStandard carePlatelet inhibitionHospitalization ratesReceptor antibodiesHospital costsMedical costsMedicare fee
1995
In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators.
Cohen D, Krumholz H, Sukin C, Ho K, Siegrist R, Cleman M, Heuser R, Brinker J, Moses J, Savage M, Detre K, Leon M, Baim D. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators. Circulation 1995, 92: 2480-7. PMID: 7586348, DOI: 10.1161/01.cir.92.9.2480.Peer-Reviewed Original ResearchConceptsMedical care costsInitial hospital costsCoronary stentingVascular complicationsConventional angioplastyBalloon angioplastyCare costsInitial hospitalizationInitial stentingHospital costsPalmaz-Schatz coronary stent implantationCatheterization laboratory costsElective coronary stentingPatient's initial hospitalizationSingle coronary lesionsSubsequent hospital visitsSubsequent revascularization proceduresSymptomatic coronary diseaseCoronary stent implantationConventional balloon angioplastyRandomized clinical trialsLength of stayDetailed resource utilizationAngiographic restenosisRepeat revascularizationImmediate results and late outcomes after stent implantation in saphenous vein graft lesions: The multicenter U.S. Palmaz-Schatz stent experience
Wong S, Baim D, Schatz R, Teirstein P, King S, Curry R, Heuser R, Ellis S, Cleman M, Overlie P, Hirshfeld J, Walker C, Litvack F, Fish D, Brinker J, Buchbinder M, Goldberg S, Chuang Y, Leon M, Group P. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: The multicenter U.S. Palmaz-Schatz stent experience. Journal Of The American College Of Cardiology 1995, 26: 704-712. PMID: 7642863, DOI: 10.1016/0735-1097(95)00217-r.Peer-Reviewed Original ResearchConceptsSaphenous vein graft lesionsVein graft lesionsGraft lesionsStent implantationDiameter stenosisStent placementActuarial event-free survivalFavorable late clinical outcomeNative coronary artery diseaseSaphenous vein graft angioplastySaphenous vein graft diseaseImproved long-term outcomesMultivariate logistic regression analysisFrequent periprocedural complicationsLate clinical outcomesStandard balloon angioplastyStent placement resultsVein graft angioplastyEvent-free survivalProcedural success rateOverall restenosis rateVein graft diseaseCoronary artery diseaseReference vessel sizeLong-term outcomesLength of hospital stay and complications after percutaneous transluminal coronary angioplasty. Clinical and procedural predictors. Heparin Registry Investigators.
Wolfe M, Roubin G, Schweiger M, Isner J, Ferguson J, Cannon A, Cleman M, Cabin H, Leya F, Bonan R, Strony J, Adelman B, Bittl J. Length of hospital stay and complications after percutaneous transluminal coronary angioplasty. Clinical and procedural predictors. Heparin Registry Investigators. Circulation 1995, 92: 311-9. PMID: 7634443, DOI: 10.1161/01.cir.92.3.311.Peer-Reviewed Original ResearchConceptsPercutaneous transluminal coronary angioplastyLength of stayMultivessel coronary artery diseasePTCA complicationsCoronary artery diseaseTransluminal coronary angioplastyHospital stayUnstable anginaBaseline variablesAdvanced ageComplex lesionsArtery diseaseCoronary angioplastyLesion complexityNon-Q-wave myocardial infarctionIndividual baseline variablesBaseline risk factorsClinical risk scoreEmergency bypass surgeryProlonged hospital staySelection of patientsAbrupt vessel closureConventional balloon angioplastyAccess of patientsStrongest predictor
1994
Long-term angiographic and clinical outcome after implantation of a ballon-expandable stent in the native coronary circulation
Savage M, Fischman D, Schatz R, Teirstein P, Leon M, Baim D, Ellis S, Topol E, Hirshfeld J, Cleman M, Buchbinder M, Bailey S, Heuser R, Walker C, Curry R, Gebhardt S, Rake R, Goldberg S, group F. Long-term angiographic and clinical outcome after implantation of a ballon-expandable stent in the native coronary circulation. Journal Of The American College Of Cardiology 1994, 24: 1207-1212. PMID: 7930240, DOI: 10.1016/0735-1097(94)90099-x.Peer-Reviewed Original ResearchConceptsNative coronary circulationAdverse clinical eventsMinimal lumen diameterClinical eventsUntreated lesionsStent implantationLumen diameterRepeat angioplastyClinical outcomesCoronary arteryCoronary circulationMyocardial infarctionEvent-free survival rateFinal minimal lumen diameterSingle Palmaz-Schatz stentsSubsequent adverse clinical eventsInitial angiographic resultsCoronary bypass surgeryNative coronary arteriesCoronary stent implantationFavorable clinical outcomeFollow-up angiographyLower restenosis rateEdge detection programPalmaz-Schatz stentsA Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease
Fischman D, Leon M, Baim D, Schatz R, Savage M, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein P, Fish R, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S. A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease. New England Journal Of Medicine 1994, 331: 496-501. PMID: 8041414, DOI: 10.1056/nejm199408253310802.Peer-Reviewed Original ResearchConceptsStandard balloon angioplastyCoronary stent placementBalloon angioplastyLarger luminal diameterAngioplasty groupProcedural successStent groupLuminal diameterOriginal target lesionRecurrent myocardial ischemiaSymptomatic coronary diseaseCoronary artery diseaseLower ratesLarge immediate increasesCoronary eventsArtery diseaseCoronary angiographyCoronary diseaseStented lesionsClinical outcomesCoronary lesionsRandomized comparisonClinical eventsCoronary stenosisStent placementPredictors of Coronary Dissection following Percutaneous Transluminal Coronary Balloon Angioplasty
Ilia R, Bigham H, Brennan J, Cabin H, Cleman M, Remetz M. Predictors of Coronary Dissection following Percutaneous Transluminal Coronary Balloon Angioplasty. Cardiology 1994, 85: 229-234. PMID: 7987880, DOI: 10.1159/000176680.Peer-Reviewed Original ResearchConceptsCoronary dissectionLong lesionsPercutaneous transluminal coronary balloon angioplastyNon-Q-wave myocardial infarctionAcute coronary dissectionCoronary balloon angioplastyConsecutive patientsCoronary angioplastyBalloon dilatationFemale patientsArterial dilatationBalloon angioplastyMyocardial infarctionMost dissectionsPatientsMore dissectionAngioplastyDissectionLesionsComplicationsArteryDilatationPredictorsInfarctionWomen
1993
Fate of lesion-related side branches after coronary artery stenting
Fischman D, Savage M, Leon M, Schatz R, Ellis S, Cleman M, Hirshfeld J, Teirstein P, Bailey S, Walker C, Goldberg S. Fate of lesion-related side branches after coronary artery stenting. Journal Of The American College Of Cardiology 1993, 22: 1641-1646. PMID: 8227832, DOI: 10.1016/0735-1097(93)90589-s.Peer-Reviewed Original ResearchConceptsSide branch occlusionStandard balloon angioplastyBalloon angioplastyBranch occlusionOstial stenosisCoronary arteryStent placementAcute side branch occlusionPalmaz-Schatz stent placementSide branchesImportant potential complicationConventional balloon angioplastySerial coronary angiographyLong-term patencySide branch ostiumPossible adverse effectsConventional angioplastyCoronary angiographyCoronary stentingMechanical obstructionPotential complicationsOstial diseaseAngioplastyPatencyCoronary stents